BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 34916290)

  • 1. Volumetric compression develops noise-driven single-cell heterogeneity.
    Zhao X; Hu J; Li Y; Guo M
    Proc Natl Acad Sci U S A; 2021 Dec; 118(51):. PubMed ID: 34916290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells.
    Andriani F; Bertolini G; Facchinetti F; Baldoli E; Moro M; Casalini P; Caserini R; Milione M; Leone G; Pelosi G; Pastorino U; Sozzi G; Roz L
    Mol Oncol; 2016 Feb; 10(2):253-71. PubMed ID: 26514616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome profiling reveals novel gene expression signatures and regulating transcription factors of TGFβ-induced epithelial-to-mesenchymal transition.
    Du L; Yamamoto S; Burnette BL; Huang D; Gao K; Jamshidi N; Kuo MD
    Cancer Med; 2016 Aug; 5(8):1962-72. PubMed ID: 27318801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549.
    Tièche CC; Gao Y; Bührer ED; Hobi N; Berezowska SA; Wyler K; Froment L; Weis S; Peng RW; Bruggmann R; Schär P; Amrein MA; Hall SRR; Dorn P; Kocher G; Riether C; Ochsenbein A; Schmid RA; Marti TM
    Neoplasia; 2019 Feb; 21(2):185-196. PubMed ID: 30591423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer.
    Schliekelman MJ; Gibbons DL; Faca VM; Creighton CJ; Rizvi ZH; Zhang Q; Wong CH; Wang H; Ungewiss C; Ahn YH; Shin DH; Kurie JM; Hanash SM
    Cancer Res; 2011 Dec; 71(24):7670-82. PubMed ID: 21987723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-κB regulates mesenchymal transition for the induction of non-small cell lung cancer initiating cells.
    Kumar M; Allison DF; Baranova NN; Wamsley JJ; Katz AJ; Bekiranov S; Jones DR; Mayo MW
    PLoS One; 2013; 8(7):e68597. PubMed ID: 23935876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
    Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
    Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
    Mittal V
    Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
    Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
    BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARP-1 induces EMT in non-small cell lung carcinoma cells via modulating the transcription factors Smad4, p65 and ZEB1.
    Kumar M; Jaiswal RK; Prasad R; Yadav SS; Kumar A; Yadava PK; Singh RP
    Life Sci; 2021 Mar; 269():118994. PubMed ID: 33417952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative gene co-expression network analysis of epithelial to mesenchymal transition reveals lung cancer progression stages.
    Wang D; Haley JD; Thompson P
    BMC Cancer; 2017 Dec; 17(1):830. PubMed ID: 29212455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High EMT Signature Score of Invasive Non-Small Cell Lung Cancer (NSCLC) Cells Correlates with NFκB Driven Colony-Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts.
    Rudisch A; Dewhurst MR; Horga LG; Kramer N; Harrer N; Dong M; van der Kuip H; Wernitznig A; Bernthaler A; Dolznig H; Sommergruber W
    PLoS One; 2015; 10(4):e0124283. PubMed ID: 25919140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of epithelial-mesenchymal transition-related markers expression in the micrometastatic sentinel lymph node of NSCLC.
    Lafuente-Sanchis A; Olmo A; Carretero J; Alcacer Fernandez-Coronado J; Estors-Guerrero M; Martínez-Hernández NJ; Cremades A; Zúñiga A; Alcacer J; Farras R; Cuenca M; Galbis-Caravajal JM
    Clin Transl Oncol; 2020 Mar; 22(3):381-391. PubMed ID: 31134511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
    Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-resistant CXCR4-positive cells have the molecular characteristics of EMT in NSCLC.
    Yin H; Wang Y; Chen W; Zhong S; Liu Z; Zhao J
    Gene; 2016 Dec; 594(1):23-29. PubMed ID: 27581786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of SATB2 is critical for induction of epithelial-to-mesenchymal transition and invasion of NSCLC cells.
    Kucuksayan H; Ozes ON; Akca H
    Lung Cancer; 2016 Aug; 98():122-129. PubMed ID: 27393518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer.
    Schaal CM; Bora-Singhal N; Kumar DM; Chellappan SP
    Mol Cancer; 2018 Oct; 17(1):149. PubMed ID: 30322398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma.
    Roudi R; Madjd Z; Ebrahimi M; Najafi A; Korourian A; Shariftabrizi A; Samadikuchaksaraei A
    Tumour Biol; 2016 Sep; 37(9):11843-11859. PubMed ID: 27048287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer.
    Wu F; Fan J; He Y; Xiong A; Yu J; Li Y; Zhang Y; Zhao W; Zhou F; Li W; Zhang J; Zhang X; Qiao M; Gao G; Chen S; Chen X; Li X; Hou L; Wu C; Su C; Ren S; Odenthal M; Buettner R; Fang N; Zhou C
    Nat Commun; 2021 May; 12(1):2540. PubMed ID: 33953163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.